HLN — HALEON Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for HALEON, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,892	9,545	10,858	11,302	11,233
Cost of Revenue
Gross Profit	6,098	5,984	6,725	6,962	7,134
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8,265	7,872	9,241	9,195	9,040
Operating Profit	1,627	1,673	1,617	2,107	2,193
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,591	1,636	1,618	1,628	1,910
Provision for Income Taxes
Net Income After Taxes	1,181	1,439	1,119	1,111	1,475
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,145	1,390	1,060	1,049	1,442
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,145	1,390	1,060	1,049	1,442
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.174	0.198	0.176	0.102	0.138
Dividends per Share